Wczytywanie spółki
Just reported
Q3 2026 results
From Heartflow's results release of 12 listopada 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
72,9M USD
+57% y/y
+14% q/qGuided
—
No guide given
Operating income, GAAP
Actual
-13,8M USD
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Heartflow is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Health Information Services
Graded A or B and worth $2B or more: A first, then the largest.
VEEVVeeva Systems Inc.49,4B USDA+
BTSGBrightSpring Health Services, Inc.14,4B USDA
HNGEHinge Health, Inc.9,9B USDA+
HQYHealthequity, Inc.8,5B USDA+
DOCSDoximity, Inc.5,9B USDB+
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
BIIBBiogen Inc.28 paź 2026BAGraded B, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki Heartflow, Inc. składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
